Literature DB >> 19309396

Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma.

Min A Kim1, Hye Seung Lee, Hee Eun Lee, Ji Hun Kim, Han-Kwang Yang, Woo Ho Kim.   

Abstract

AIMS: Epithelial-mesenchymal transition (EMT) is defined as switching of polarized epithelial cells to a migratory fibroblastoid phenotype. EMT is known to be involved in the progression and metastasis of various cancers. The aim was to evaluate the expression of EMT-related proteins in gastric carcinoma (GC). METHODS AND
RESULTS: The expression of nine EMT-related proteins in the GC tissues of 598 patients was evaluated by immunohistochemistry using a tissue array method. In addition, clinicopathological characteristics and survival were compared with the expression of EMT-related proteins. Loss of epithelial protein and/or acquisition of the expression of mesenchymal proteins were observed in GC. These protein alterations were associated with diffuse type histology, advanced stage and poor patient outcome, respectively. Subjects were divided into three groups according to degree of EMT-related protein alteration. Increases in alteration of EMT-related protein were found to be significantly associated with poorly differentiated histology, higher pTNM stage and unfavourable outcome. Multivariate analysis showed that alterations in the expression of EMT-related proteins were independently associated with poor prognosis.
CONCLUSIONS: Loss of epithelial proteins and/or the acquisition of mesenchymal proteins are associated with poorly differentiated histology, advanced stage and poor outcome in GC. The awareness and inhibition of EMT offer a promising target for prevention of metastatic progression and invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309396     DOI: 10.1111/j.1365-2559.2009.03247.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  63 in total

1.  S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.

Authors:  Dong Chen; Xue-Feng Zheng; Ze-You Yang; Dong-Xiao Liu; Guo-You Zhang; Xue-Long Jiao; Hui Zhao
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

3.  Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer.

Authors:  Zhan-shan Wang; Yang Shen; Xu Li; Chong-zhi Zhou; Yu-gang Wen; Yu-biao Jin; Ji-kun Li
Journal:  Tumour Biol       Date:  2013-10-01

4.  Prognostic value of multiple epithelial mesenchymal transition-associated proteins in intrahepatic cholangiocarcinoma.

Authors:  Xiangguo Tian; Zhixin Cao; Qian Ding; Zhen Li; Chunqing Zhang
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

5.  Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Authors:  Jie Gu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Zong-wu Lin; Jian-yong Ding; Di Ge
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

6.  PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment.

Authors:  Xiaoyu Wang; Libing Wang; Yan Xu; Guohua Zhang; Yunlin Wu; Ping Chen
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

7.  MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.

Authors:  Ning Duan; Xiaojing Hu; Xiaowei Yang; Huiguang Cheng; Wentao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Authors:  Guy Lahat; Quan-Sheng Zhu; Kai-Lieh Huang; Suizhao Wang; Svetlana Bolshakov; Jeffery Liu; Keila Torres; Robert R Langley; Alexander J Lazar; Mien Chie Hung; Dina Lev
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

9.  Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.

Authors:  Y Kato; M Yashiro; S Noda; M Tendo; S Kashiwagi; Y Doi; T Nishii; J Matsuoka; Y Fuyuhiro; O Shinto; T Sawada; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer.

Authors:  Yasuhiko Kitadai
Journal:  Cancer Microenviron       Date:  2009-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.